Projects / Programmes
The use of methoxyamine to study abasic site induced mutagenesis in bacterial strains
Code |
Science |
Field |
Subfield |
4.06.04 |
Biotechnical sciences |
Biotechnology |
Microbe biotechnology |
Code |
Science |
Field |
B220 |
Biomedical sciences |
Genetics, cytogenetics |
methoxyamine, antimutagen, DNA repair, apurinic/apirimidinic sites, alkylating agents, E. coli
Researchers (1)
no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
1. |
09892 |
PhD Metka Filipič |
Biology |
Head |
1998 - 1999 |
0 |
Organisations (1)
no. |
Code |
Research organisation |
City |
Registration number |
No. of publicationsNo. of publications |
1. |
0105 |
National Institute of Biology |
Ljubljana |
5055784 |
0 |
Abstract
Abasic sites are common intermediates involved in processes of mutagenesis and carcinogenesis. They are formed spontaneously and their formation is enhanced by various chemical and physical agents. Their role in these processes is not jet totally understood. Methoxyamine (MX) is a nucleofilic reagent able to specifically react with abasic sites. It was shown that MX is able to protect mammalian cells against cytotoxicity, mutagenicity and sister chromatide exchanges induced by SN1 alkylating agents. These results suggested that abasic sites are important component of alkylation induced mutagenesis.
We propose the use of different E. coli strains which are impaired in different repair functions to investigate the formation and processing of AP sites in vivo. Bacterial strains offer the advantage, as compared to mammalian cells, because of availability of a wide spectrum of mutant strains impaired in different genes coding for repair enzymes. The use of these strains will allow to elucidate the role of different DNA repair functions in the formation and processing of abasic sites.
Methoxyamine will be used as a tool to identify AP site mediated mutagenesis and its use as a molecular probe in vivo for AP site formation will be investigated.